Patents/Assignees

Ikena Oncology, Inc.

10 patents in portfolio

US12459895utility2025
MEK Inhibitors and Uses Thereof
0 cites
US12162884utility2024
Solid Forms of (r)-n-(2-(5-fluoropyridin-3-yl)-8-isopropylpyrazolo[1,5-a] [1,3,5]triazin-4-yl)-2,3,4,9-tetrahydro-1h-carbazol-3-amine as Aryl Hydrocarbon Receptor (AHR) Inhibitors
0 cites
US12077542utility2024
Indole AHR Inhibitors and Uses Thereof
0 cites
US12030876utility2024
Aryl Hydrocarbon Receptor (AHR) Agonists and Uses Thereof
0 cites
US11925651utility2024
TEAD Inhibitors and Uses Thereof
0 cites
US11878958utility2024
MEK Inhibitors and Uses Thereof
0 cites
US11760728utility2023
Tead Inhibitors and Uses Thereof
0 cites
US11608329utility2023
Aryl Hydrocarbon Receptor (AHR) Agonists and Uses Thereof
0 cites
US11591339utility2023
Solid Forms of (r)-n-(2-(5-fluoropyridin-3-yl)-8-isopropylpyrazolo[ 1,5-a][1,3,5]triazin-4-yl)-2,3,4,9-tetrahydro-1h-carbazol-3-amine Maleate as Aryl Hydrocarbon Receptor (AHR) Inhibitors
0 cites
US11555026utility2023
AHR Inhibitors and Uses Thereof
0 cites